Parathyroid hormone-related protein mRNA expression and oral cancer progression

甲状旁腺激素相关蛋白 mRNA 表达与口腔癌进展

基本信息

  • 批准号:
    05557081
  • 负责人:
  • 金额:
    $ 6.72万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1995
  • 项目状态:
    已结题

项目摘要

Parathyroid hormone-related protein (PTHrP) was originally isolated from sequamous carcinoma from patients with hypercalcemia of malignancy. PTHrP and Parathyroid hormone (PTH) share similar biochemical properties such as bone resorption, phosphaturia and increased production of 1alpha, 25-dihydroxyvitamin D_3 [1,25 (OH)_2D_3]. Moreover, PTHrP acts through the same membrane receptor as PTH.In the present investigation, following results were obtained.1.PTHrP mRNA abundance in biopsies was increased in progressive oral cancer, although hypercalcemia did not emerge from all of the patients.2.The regulation of PTHrP expression was studied in oral cancer cell line (HSC-3). The active form of vitamin D,1,25 (OH)_2D_3, inhibited PTHrP gene expression and the production in a dose-dependent manner.3.To study the relationship between PTHrP expression and serum 1,25 (OH)_2D_3, a simple and sensitive 1,25 (OH)_2D_3 assay was developed.4.The influence of PTHrP and PTH on 1,25 (OH)_2D_3 metabolism was assessed. A critical enzyme for 1,25 (OH)_2D_3 degradation, 24-hydroxylase, was focused. PTH and PTHrP inhibited the activity of 24-hydroxylase but did not affect the gene expression.PTHrP gene expression may be very important for a parameter of the progress of oral cancer. We are proceeding with the investigation on the relationship between PTHrP and tumor marker gene expression in various stages of cancer biopsies.
甲状旁腺素相关蛋白(PTHrP)最初是从恶性高钙血症患者的鳞状细胞癌中分离出来的。PTHrP与甲状旁腺激素(PTH)具有相似的生化特性,如骨吸收、磷酸盐尿和增加1 α,25-二羟维生素D_3 [1,25(OH)_2D_3]的产生。本研究的主要结果如下:1.口腔癌组织中PTHrP mRNA的表达水平在进展期口腔癌中明显升高,但并不一定伴有高钙血症; 2.研究了口腔癌细胞系HSC-3中PTHrP的表达调控。为研究PTHrP表达与血清1,25(OH)_2D_3的关系,建立了一种简便、灵敏的1,25(OH)_2D_3测定方法。重点研究了1,25(OH)_2D_3降解的关键酶24-羟化酶。PTH和PTHrP抑制24-羟化酶的活性,但不影响基因表达,PTHrP基因表达可能是口腔癌发生发展的一个重要参数。我们正在进行的调查PTHrP和肿瘤标志物基因表达在不同阶段的癌症活检之间的关系。

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Akeno N.: "Increase of renal 25-hydroxyvitamin D_3-24-hydroxylase activity and its messenger ribonucleic acid level in 1α-hydroxyvitamin D_3-administered rats : Possibility of the presence of two forms of 24-hydroxylase." Journal of Nutritional Science an
Akeno N.:“给予 1α-羟基维生素 D_3 的大鼠肾脏 25-羟基维生素 D_3-24-羟化酶活性及其信使核糖核酸水平增加:营养科学杂志和杂志上存在两种形式的 24-羟化酶的可能性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Horiuchi N.: "Synthesis of 25-hydroxyvitamin D_3-26,23-lactone but not 24,25-dihydroxyvitamin D_3 from 25-hydroxyvitamin D_3 in opossum kidney cells treated with 1α,25-dihydroxyvitamin D_3." Hormone and Metabolic Research. 27. 83-89 (1995)
Horiuchi N.:“在用 1α,25-二羟基维生素 D_3 处理的负鼠肾细胞中从 25-羟基维生素 D_3 合成 25-羟基维生素 D_3-26,23-内酯,而不是 24,25-二羟基维生素 D_3。” .83-89 (1995)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Noboru Horiuchi: "Synthesis of 25-hydroxyvitaminD_3-26,23-lactone but not 24,25-dihydroxyvitaminD_3 from 25-hydroxyvitaminD_3 in opossum kidney cells treated with 1α, 25-dihydroxyvitaminD_3" Hormone and Metabolic Research. 27. 83-89 (1995)
Noboru Horiuchi:“用 1α, 25-二羟基维生素 D_3 在负鼠肾处理的细胞中从 25-羟基维生素 D_3 合成 25-羟基维生素 D_3-26,23-内酯,但不是 24,25-二羟基维生素 D_3”激素和代谢研究 27. 83-89 (1995)。 )
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Akeno N,Saikatsu S,Kimura S,Horiuchi N: "Induction of vitamin D 24-hydroxylase messenger RNA and activity by 22-oxacalcitriol in mouse kidney and duodenum : Possible role in decrease of plasma 1alpha, 25-dihydroxyvitamin D_3" Biochem.Pharmacol.48 (11). 20
Akeno N、Saikatsu S、Kimura S、Horiuchi N:“小鼠肾脏和十二指肠中 22-oxacalcitriol 诱导维生素 D 24-羟化酶信使 RNA 和活性:在血浆 1α、25-二羟基维生素 D_3 减少中的可能作用”Biochem.Pharmacol
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sachiko Saikatsu: "Comparison of single cartridge (C18/OH) and high performance liquid chromatography sample purification for the thymus radioreceptor assay of 1,25(OH)_2D." Klinisches Labor. 39. 737-744 (1993)
Sachiko Saikatsu:“用于 1,25(OH)_2D 胸腺放射受体测定的单筒 (C18/OH) 和高效液相色谱样品纯化的比较。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HORIUCHI Noboru其他文献

HORIUCHI Noboru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HORIUCHI Noboru', 18)}}的其他基金

Elucidation of Regulatory Mechanisms of Osteoblastic and Chondrocytic Differentiation by Statins
他汀类药物对成骨细胞和软骨细胞分化的调节机制的阐明
  • 批准号:
    18592045
  • 财政年份:
    2006
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of osteoblast differantiation by statins via stimulation of VEGF gene transcription
他汀类药物刺激 VEGF 基因转录分化成骨细胞的机制
  • 批准号:
    15591976
  • 财政年份:
    2003
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Disorder of vitamin D metabolism in steroid-induced osteoporosis
类固醇引起的骨质疏松症中维生素 D 代谢紊乱
  • 批准号:
    10470393
  • 财政年份:
    1998
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).

相似海外基金

Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
  • 批准号:
    10991546
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
Detection of novel therapeutic targets and biomarkers via identification of beneficial oral/ gut bacteria to enhance the response of PD1/PD-L1 blockade therapy in oral cancer patients
通过鉴定有益的口腔/肠道细菌来检测新的治疗靶点和生物标志物,以增强口腔癌患者 PD1/PD-L1 阻断疗法的反应
  • 批准号:
    24K13070
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Application of IL-1RA to the sensitizing and mucositis-preventive effects of oral cancer radiotherapy.
IL-1RA在口腔癌放疗增敏和预防粘膜炎中的应用。
  • 批准号:
    23K08931
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of carcinomatous bone pain in oral cancer focusing on mct4 and development of new therapeutic agents
以MCT4为中心阐明口腔癌癌性骨痛机制并开发新治疗药物
  • 批准号:
    23K16147
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
深度学习图像分析算法可改善口腔潜在恶性疾病的口腔癌风险评估
  • 批准号:
    10805177
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
A point-of-care salivary cytokine test for early detection of oral cancer
用于早期发现口腔癌的即时唾液细胞因子检测
  • 批准号:
    10760626
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
Role of IQGAPs, a small GTPase target protein, in the regulation of oral cancer progression
IQGAP(一种小 GTP 酶靶蛋白)在调节口腔癌进展中的作用
  • 批准号:
    23K09145
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proposal of a high-throughput 3D culture system and novel resistance mechanisms of oral cancer
口腔癌高通量3D培养系统和新型耐药机制的提出
  • 批准号:
    23K09317
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the development of antibody-drug conjugate orphan drugs based on photodynamic therapy targeting oral cancer.
基于口腔癌光动力疗法的抗体药物偶联孤儿药的开发研究。
  • 批准号:
    23K09344
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel molecular mechanism of oral cancer pain focused attention on plastic changes in intercellular network in the trigeminal ganglion
口腔癌疼痛的新分子机制关注三叉神经节细胞间网络的可塑性变化
  • 批准号:
    23H03108
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了